🇺🇸 FDA
Patent

US 10584313

Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere

granted A61PA61P1/04A61P1/16

Quick answer

US patent 10584313 (Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere) held by Astellas Institute for Regenerative Medicine expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P1/04, A61P1/16, A61P13/00, A61P13/12